Page last updated: 2024-11-02

pirenzepine and Hemorrhagic Shock

pirenzepine has been researched along with Hemorrhagic Shock in 2 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, N1
Quan, LH1
Kawano, S1
Kamada, T1
Abe, H1
Guarini, S1
Tagliavini, S1
Bazzani, C1
Pasini, M1
Bertolini, A1

Other Studies

2 other studies available for pirenzepine and Hemorrhagic Shock

ArticleYear
Effect of H2 receptor- and muscarine receptor antagonists and prostaglandin E1 analog on the gastric mucosal hemodynamics and oxygen sufficiency in rats.
    Advances in experimental medicine and biology, 1984, Volume: 180

    Topics: Alprostadil; Animals; Benzodiazepinones; Gastric Mucosa; Hemodynamics; Histamine H2 Antagonists; Mal

1984
Brain M3 muscarinic receptors are involved in the ACTH-induced reversal of hemorrhagic shock.
    Naunyn-Schmiedeberg's archives of pharmacology, 1990, Volume: 342, Issue:1

    Topics: Adrenocorticotropic Hormone; Animals; Blood Pressure; Brain Chemistry; Female; Heart Rate; Injection

1990